title: Topoisomerase II from Chlorella virus PBCV-1 has an exceptionally high DNA cleavage activity.
abstract: Chlorella virus PBCV-1 topoisomerase II is the only functional type II enzyme known to be encoded by a virus that infects eukaryotic cells. However, it has not been established whether the protein is expressed following viral infection or whether the enzyme has any catalytic features that distinguish it from cellular type II topoisomerases. Therefore, the present study characterized the physiological expression of PBCV-1 topoisomerase II and individual reaction steps catalyzed by the enzyme. Results indicate that the topoisomerase II gene is widely distributed among Chlorella viruses and that the protein is expressed 60-90 min after viral infection of algal cells. Furthermore, the enzyme has an extremely high DNA cleavage activity that sets it apart from all known eukaryotic type II topoisomerases. Levels of DNA scission generated by the viral enzyme are approximately 30 times greater than those observed with human topoisomerase IIalpha. The high levels of cleavage are not due to inordinately tight enzyme-DNA binding or to impaired DNA religation. Thus, they most likely reflect an elevated forward rate of scission. The robust DNA cleavage activity of PBCV-1 topoisomerase II provides a unique tool for studying the catalytic functions of type II topoisomerases.
authors.affiliation: Departments of Biochemistry and Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Fortune
authors.forename: O V
authors.initials: OV
authors.lastname: Lavrukhin
authors.forename: J R
authors.initials: JR
authors.lastname: Gurnon
authors.forename: J L
authors.initials: JL
authors.lastname: Van Etten
authors.forename: R S
authors.initials: RS
authors.lastname: Lloyd
authors.forename: N
authors.initials: N
authors.lastname: Osheroff
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology; D002412:Cations / Q000737:chemistry; D002708:Chlorella / Q000821:virology*; D004247:DNA / Q000378:metabolism; D004250:DNA Topoisomerases, Type II / Q000235:genetics / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D005047:Etoposide / Q000494:pharmacology; D005814:Genes, Viral; D006801:Humans; D017862:Phycodnaviridae / Q000201:enzymology*; D012367:RNA, Viral / Q000096:biosynthesis; D059005:Topoisomerase II Inhibitors; D014764:Viral Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D002412:Cations; D004268:DNA-Binding Proteins; D012367:RNA, Viral; D059005:Topoisomerase II Inhibitors; D014764:Viral Proteins; D005047:Etoposide; D000255:Adenosine Triphosphate; D004247:DNA; D004250:DNA Topoisomerases, Type II